[{"Assets_0_Q2_USD":42446000.0,"CommonStockSharesOutstanding_0_Q2_shares":37369895.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-17301000.0,"NetIncomeLoss_1_Q2_USD":-12004000.0,"NetIncomeLoss_2_Q2_USD":-22976000.0,"StockholdersEquity_0_Q2_USD":37408000.0,"Ticker":"PRVB","CIK":"1695357","name":"PROVENTION BIO, INC.","OfficialName":"Provention Bio Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"371519921.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]